Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung fun...
Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
About this item
Full title
Author / Creator
Weigold, Florian , Günther, Jeannine , Pfeiffenberger, Moritz , Cabral-Marques, Otavio , Siegert, Elise , Dragun, Duska , Philippe, Aurélie , Regensburger, Ann-Katrin , Recke, Andreas , Yu, Xinhua , Petersen, Frank , Catar, Rusan , Biesen, Robert , Hiepe, Falk , Burmester, Gerd R. , Heidecke, Harald and Riemekasten, Gabriela
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The chemokine receptors CXCR3 and CXCR4 are involved in the pathogenesis of fibrosis, a key feature of systemic sclerosis (SSc). It is hypothesized that immunoglobulin (Ig)G antibodies (abs) against these two receptors are present in patients with SSc and are associated with clinical findings.
Anti-CXCR3 and anti-CXCR4 ab levels were measured in...
Alternative Titles
Full title
Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f50c80a2895a44a68faedb894ed28ddd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f50c80a2895a44a68faedb894ed28ddd
Other Identifiers
ISSN
1478-6362,1478-6354
E-ISSN
1478-6362
DOI
10.1186/s13075-018-1545-8
